GENE ONLINE|News &
Opinion
Blog

2022-05-23| COVID-19Special

Learning From the COVID-19 Pandemic With Moderna CEO, Stéphane Bancel

by Reed Slater
Share To

Over two years into the COVID-19 pandemic, the world has experienced and learned so much about viruses, epidemic response, vaccine technology, and everything else that comes along with living through a global epidemic. At the Future of Everything Festival, Moderna CEO Stéphane Bancel sits down and recounts some valuable lessons the pharmaceutical giant has learned over this time and highlights some hopeful prospects for the future after the pandemic. 

 

Where COVID May Be Heading

 

Over 6 million people worldwide have died due to COVID-19 since it began in late 2019. However, the dominant variant, Omicron, is less dangerous than its predecessors. Though much more virulent, Omicron shows milder symptoms across the board and, compared to Alpha and Delta, is showing signs it may be the light at the end of the tunnel. 

It's free! Log in now to read

LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top